CVS Group Continues Share Buyback, Cancels Additional Shares

CVS Group plc ( (GB:CVSG) ) has issued an announcement.

CVS Group plc has continued its share buyback programme with the repurchase of 16,102 ordinary shares on 22 December 2025 at prices between 1,252p and 1,270p per share, for a volume-weighted average of 1,263.81p. The company will cancel these shares, reducing the number of shares in issue to 70,753,114 and leaving no shares held in treasury, a move that marginally enhances earnings per share and signals ongoing capital management discipline; since the programme began, CVS has bought back a total of 987,669 shares at an average price of 1,218.81p, refining its capital structure and potentially supporting shareholder value.

The most recent analyst rating on (GB:CVSG) stock is a Hold with a £1320.00 price target. To see the full list of analyst forecasts on CVS Group plc stock, see the GB:CVSG Stock Forecast page.

Spark’s Take on GB:CVSG Stock

According to Spark, TipRanks’ AI Analyst, GB:CVSG is a Neutral.

CVS Group plc’s overall stock score is driven by strong financial performance and positive earnings call highlights, including revenue growth and successful acquisitions. However, the high P/E ratio and low dividend yield suggest overvaluation, while technical indicators point to potential overbought conditions. Challenges in the UK market and past cyber incidents also weigh on the score.

To see Spark’s full report on GB:CVSG stock, click here.

More about CVS Group plc

CVS Group plc is an AIM-listed provider of veterinary services with operations in the UK and Australia, focused on delivering high-quality clinical care to clients and their animals across its network of practices.

Average Trading Volume: 444,443

Technical Sentiment Signal: Buy

Current Market Cap: £891.9M

Find detailed analytics on CVSG stock on TipRanks’ Stock Analysis page.